The Patent Finder

GlaxoSmithKline S.P.A.

Also on record
Records under this name other than the patents GlaxoSmithKline S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to GlaxoSmithKline S.P.A.

PatentTitleStatus Expires Confidence
US 9,216,967Imidazolidinedione Derivatives
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,849,131Imidazolidinedione Derivatives
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,632,118Imidazolidinedione Derivatives
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,722,695Imidazolidinedione Derivatives
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,265,316Hydantoin Derivatives Useful as KV3 Inhibitors
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,197,859Hydantoin Derivatives Useful as KV3 Inhibitors
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,583,527Hydantoin Derivatives Useful as KV3 Inhibitors
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,346,790Hydantoin Derivatives Useful as KV3 Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,261,404Apparatus for Testing Samples Using Raman Radiation
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,422,252Triazoles as KV3 Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
10 of 38 patents shown.
Pro members see all 38.
Pro members: see all 38 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited